Advance Care Planning Individualised Approach and Research Projec (AIR)

February 9, 2021 updated by: Kristoffer Marsaa, Herlev and Gentofte Hospital

The AIR Project - Advance Care Planning Individualised Approach and Research Project. A Single Center Randomized Controlled Trial

The study will investigate the effect of a palliative approach in the out-patient management of patients with COPD.

Study Overview

Status

Terminated

Conditions

Intervention / Treatment

Detailed Description

Randomised control trial. A total of 90 patients will be randomise 1:1 to either palliative intervention or standard care.

The intervention group will receive follow up in a newly established outpatient clinic for COPD in the specialized palliative united and the control group will receive standard follow up in the respiratory out-patient clinic.

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Herlev/ Reghion H
      • Copenhagen, Herlev/ Reghion H, Denmark, 2730
        • Herlev & Gentofte hoospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • • Diagnosis of COPD by spirometry

    • Patients followed in Herlev and Gentofte hospitals' respiratory out-patient-clinics or admitted to Herlev or Gentofte hospital for acute exacerbation
    • 2 or more admissions for acute exacerbation of COPD within the last 12 months
    • CAT > 20
    • Cognitive and linguistic able to understand and give informed consent

Exclusion Criteria:

  • • Expected remaining life time less than 6 months due to other disease than COPD e.g. active cancer

    • Participating in other studies

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Palliative care
Specialized palliative care arm in a newly formed COPD outpatient clinic
complex and multi-faceted individualized palliative care
No Intervention: Usual care
Usual care in a standard pulmonary out-patient clinic. Treatment as described in national standards.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline in total Hospital and Anxiety Depression scale (HADS) at 6 months
Time Frame: baseline, 3 and 6 months
questionnaire measuring anxiety and Depression in 2 subscales in this study we use the total value of the 2 subscales combined. The higher the number the worse the psychological impact. HADS total was a range from 0 to 24 where 0 is no psychological distress
baseline, 3 and 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline EORTC QLQ-C15-PAL at 6 months
Time Frame: baseline, 3 and 6 months
questionnaire, consists of 14 questions and a license audit goal from 1 to 7 where 7 is the best possible quality of life.For the first 14 questions about symptoms, the scale goes from 1 to 4 where 4 is the worst
baseline, 3 and 6 months
Change from Baseline Life-Space Assessment (LSA) at 6 months
Time Frame: baseline, 3 and 6 months
questionnaire,5 questions about where the patient has been in the last 4 weeks. Question 1 is other than bedroom and question 5 is out of his home town. In addition, questions are asked about how frequently and on the use of aids.finally the scales are converted to numerical value between 0 and 120 where 0 is worst and expresses that the patient is constant in bed
baseline, 3 and 6 months
Change from Baseline copd assessment test (CAT) at 6 months
Time Frame: baseline, 3 and 6 months
questionnaire. 8 items questionnaire where there should be between 0 and 5 where 5 is the worst. Together, this gives a total scale between 0 and 40 where 40 is worst
baseline, 3 and 6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adherence at 6months
Time Frame: 6 months
measured by inhaled medicine bought at the pharmacy. Data is gather from a national database
6 months
Change from Baseline Use of out-patient clinic at 6 months
Time Frame: baseline to 6 months
number of out-patient clinic visits
baseline to 6 months
Change from Baseline in admission frequency at 6 months
Time Frame: baseline to 6 month
numbers of admissions in the study periode
baseline to 6 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Jens-Ulrik Jensen, Phd MD, pulmonary department Herlev and Gentofte Hospital
  • Study Director: Torgny Wilcke Wilcke, phd MD, pulmonary department Herlev and Gentofte Hospital
  • Study Director: Janni Mendahl, APN, Palliative Unite Herlev and Gentofte Hospital
  • Study Director: Charlotte Ulrik, Prof. MD DMSc, Pulmonary department Hvidovre Hospital
  • Study Chair: Nina Godtfredsen, phd MD, Pulmonary department Hvidovre Hospital
  • Principal Investigator: Kristoffer Marså, MD, Palliative Unite Herlev and Gentofte Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2019

Primary Completion (Actual)

November 1, 2020

Study Completion (Actual)

November 1, 2020

Study Registration Dates

First Submitted

January 27, 2019

First Submitted That Met QC Criteria

April 14, 2019

First Posted (Actual)

April 16, 2019

Study Record Updates

Last Update Posted (Actual)

February 12, 2021

Last Update Submitted That Met QC Criteria

February 9, 2021

Last Verified

February 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • AIR

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Severe COPD

Clinical Trials on palliative care

Subscribe